title: Will Bivalirudin Have an Impact in Peripheral Vascular Interventions?
authors.affiliation: From the Division of Cardiovascular Medicine, Department of Medicine, University Hospitals Case Medical Center, Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH (S.A.P.); and Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (D.E.D.). sahil.parikh@uhhospitals.org.
authors.forename: Sahil A
authors.initials: SA
authors.lastname: Parikh
authors.affiliation: From the Division of Cardiovascular Medicine, Department of Medicine, University Hospitals Case Medical Center, Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, OH (S.A.P.); and Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (D.E.D.).
authors.forename: Douglas E
authors.initials: DE
authors.lastname: Drachman
mesh_terms: D006801:Humans; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins
keywords: Editorials; bivalirudin; hemorrhage; percutaneous coronary intervention; peripheral arterial disease